-
White House, USPS solidify plans to distribute 500M COVID-19 tests
The U.S. government is finalizing a plan with the U.S. Postal Service to distribute 500 million COVID-19 tests to households nationwide, four people familiar with the matter told The Washington Post. -
Top supply chain breakthroughs to learn from in 2022
With supply chain leaders in the healthcare industry facing numerous challenges in 2021, it’s important to also highlight the successes from the past year as well. -
800K expired COVID-19 tests found in state stockpile, Florida governor says
Anywhere from 800,000 to 1 million COVID-19 tests expired in a state stockpile, Florida Gov. Ron DeSantis revealed during a Jan. 6 news conference, NBC2 News reported. -
Health systems ration COVID-19 treatments as cases surge
Supply shortages and surging COVID-19 cases have prompted health systems across the country to ration treatments, The New York Times reported Jan. 6. -
Florida medical supply company to pay $600K in Medicare fraud settlement
Owners of an Orlando-based medical supply company have agreed to pay $600,000 to resolve allegations they participated in a scheme to defraud Medicare. -
10 systems seeking supply chain talent
Ten health systems have posted job listings for supply chain expertise in the last week: -
US plant backed by 34 systems to produce 40M medical gowns annually
A domestic medical gown manufacturing plant funded by 34 health systems will start production in early spring. -
Washington state to distribute 5.5M at-home tests
Washington state will distribute 5.5 million rapid at-home COVID-19 tests to residents over the coming weeks, Governor Jay Inslee said during a Jan. 5 media briefing. -
Officials warn Chicago, Philadelphia residents of fake COVID-19 testing sites
Officials in Chicago and Philadelphia are warning residents to be aware of fake COVID-19 tests and testing sites given the scarcity of supplies during the recent surge of cases. -
Indiana limits eligibility for rapid COVID-19 tests
Rapid COVID-19 tests at Indiana state and local health department testing sites will only be available to individuals aged 18 and younger and symptomatic individuals aged 50 and older, according to new guidelines issued by the Department of Health Jan. 4. -
Walmart, Kroger raise rapid test prices
Following the end of a three-month agreement with the federal government to sell at-home COVID-19 tests at a lower price, Walmart and Kroger have raised the prices of Abbott Laboratories' BinaxNow testing kits, NBC News reported Jan. 4. -
South Carolina hospital supplier now selling COVID-19 tests to the public
Columbia, S.C.-based Rhino Medical Supply is now selling at-home COVID-19 tests to the public as cases surge in the state, Fox affiliate WACH reported Jan. 4. -
Healthcare Supply Chain Association names 2022 board chair
The Healthcare Supply Chain Association named Jennifer Gedney, Children’s Hospital Association vice president of supply chain services, chair of Board of Directors, the organization said Jan. 4. -
Linet sues Hillrom over hospital bed sales
Chicago-based medical technology company Hillrom is being sued by Linet, a global supplier of hospital beds, for allegedly using "anti-competitive" practices to slow the supplier's growth in the U.S., the Chicago Tribune reported Dec. 29. -
Florida governor to US: Allow states to buy antibody treatments
Florida Gov. Ron DeSantis is urging the federal government to allow states to buy monoclonal antibody treatments amid the latest COVID-19 surge, The Hill reported Jan. 3. -
Tennessee receives oral antiviral COVID-19 supply
The Tennessee Department of Health has received a limited supply of the Merck and Pfizer oral antiviral treatments for COVID-19. -
6 systems reporting antibody treatment shortages
Health systems across the nation are reporting shortages in sotrovimab, which The New York Times reported is the only COVID-19 monoclonal antibody treatment that appears to be effective against the omicron variant. -
10 systems seeking supply chain talent
Ten health systems have posted job listings for supply chain expertise in the last week: -
Antigen tests may be less sensitive to omicron, FDA warns
Rapid antigen tests may have reduced sensitivity in detecting the omicron COVID-19 variant, the FDA said in a Dec. 28 update. -
Supply Chain Tip of the Week: Supporting your staff and boosting resilience
Between the struggles of COVID-19 and the constant supply challenges, the past two years have been exhausting for healthcare workers.
Page 43 of 50